prednisone has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Excerpt | Relevance | Reference |
---|---|---|
"Letrozole has been applied during controlled ovarian hyperstimulation (COH) to reduce the rate of OHSS in women undergoing long-term Gonadotropin-releasing Hormone Analog (GnRHa) treatment for assisted fertility." | 5.62 | Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone analog treatment. ( Chen, H; Cheng, J; Fang, L; Qu, X; Ruan, M; Yang, S; Zhao, J, 2021) |
"Letrozole has been applied during controlled ovarian hyperstimulation (COH) to reduce the rate of OHSS in women undergoing long-term Gonadotropin-releasing Hormone Analog (GnRHa) treatment for assisted fertility." | 1.62 | Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone analog treatment. ( Chen, H; Cheng, J; Fang, L; Qu, X; Ruan, M; Yang, S; Zhao, J, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fang, L | 1 |
Ruan, M | 1 |
Yang, S | 1 |
Qu, X | 1 |
Chen, H | 1 |
Zhao, J | 1 |
Cheng, J | 1 |
1 other study available for prednisone and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous
Article | Year |
---|---|
Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone analog treatment.
Topics: Female; Gonadotropin-Releasing Hormone; Humans; Letrozole; Ovarian Hyperstimulation Syndrome; Ovulat | 2021 |